Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose Infusion.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2016-08-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JC.2016-1948PMID 27533305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence of Extrapancreatic Glucagon Secretion in Man

  2015cited by this paper
• Glucose and glycerol concentrations and their tracer enrichment measurements using liquid chromatography tandem mass spectrometry.

  2014cited by this paper
• Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes

  2014cited by this paper
• Direct effect of GLP-1 infusion on endogenous glucose production in humans

  2012cited by this paper
• Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.

  2011cited by this paper
• The metabolic actions of glucagon revisited

  2010cited by this paper
• Four grams of glucose.

  2009cited by this paper
• Application of Isotopic Techniques Using Constant Specific Activity or Enrichment to the Study of Carbohydrate Metabolism

  2009cited by this paper
• Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

  2007cited by this paper
• Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects

  2007cited by this paper
• Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes

  2006cited by this paper
• Endogenous Glucose Production in Type 2 Diabetes: Basal and Postprandial. Role of Diurnal Rhythms

  2004cited by this paper
• Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.

  2003cited by this paper
• Quantitation of basal endogenous glucose production in Type II diabetes: importance of the volume of distribution

  2002cited by this paper
• Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

  1998cited by this paper
• Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans.

  1998cited by this paper
• Hepatic Glucose Production Is Regulated Both by Direct Hepatic and Extrahepatic Effects of Insulin in Humans

  1996cited by this paper
• Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

  1994cited by this paper
• Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.

  1994cited by this paper
• Glucose fluxes and oxidation after an oral glucose load in patients with non-insulin-dependent diabetes mellitus of variable severity.

  1993cited by this paper
• Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM

  1990cited by this paper
• Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.

  1990cited by this paper
• Assessment of the postprandial pattern of glucose metabolism in nondiabetic subjects and patients with non-insulin-dependent diabetes mellitus using a simultaneous infusion of [2(3)H] and [3(3)H] glucose.

  1989cited by this paper
• The disposal of an oral glucose load in patients with non-insulin-dependent diabetes.

  1988cited by this paper
• Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.

  1986cited by this paper
• Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.

  1980cited by this paper
• Experimental validation of measurements of glucose turnover in nonsteady state.

  1978cited by this paper
• The role of the liver in glucagon metabolism.

  1977cited by this paper
• Glucose Uptake and Production During the Oral Glucose Tolerance Test

  1968cited by this paper

• Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases

  2023cites this paper
• Demystifying Dietary Sugars

  2022cites this paper
• Increased serum cystatin C levels and responses of pancreatic α- and β-cells in type 2 diabetes

  2022cites this paper
• Evidence for glucagon secretion and function within the human gut.

  2021cites this paper
• Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus

  2021influential citation
• Solanum anguivi Lam. Fruits: Their Potential Effects on Type 2 Diabetes Mellitus

  2021cites this paper
• Changes in OGTT‐derived biomarkers in response to lifestyle intervention among Latino adolescents with obesity

  2021cites this paper
• Extrapancreatic glucagon: Present status.

  2019cites this paper
• Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

  2018cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 248 Mechanism-based modelling of clinical and preclinical studies of glucose homeostasis

  2018cites this paper
• Gut Mechanisms Linking Intestinal Sweet Sensing to Glycemic Control

  2018cites this paper
• A gut feeling about glucagon

  2018cites this paper
• EJE PRIZE 2018: A gut feeling about glucagon.

  2018cites this paper